
Benign prostatic hyperplasia symptoms represent one of the most widespread health challenges for men worldwide. This non-cancerous enlargement of the prostate gland affects approximately 45% of men over 45 years of age, with the prevalence increasing to about 80% in men over 70. The burden of BPH varies significantly across regions and...

Ovarian cancer is one of the most common gynecological malignancies affecting women worldwide. According to the latest statistics, ovarian cancer is the eighth most common cancer among women worldwide, with approximately 313,000 new cases diagnosed each year. Due to the lack of specific symptoms, the disease is very difficult to diagnose...

Stage 4 of breast cancer is called advanced or metastatic. At this step, the tumor spreads beyond the breast to other organs. The American Cancer Society estimates that there will be 316,950 new cases of invasive breast cancer in women in the US in 2025. In the UK, there could be around 69,900 new cases every year by 2038-2040.

Arthrosis affects millions worldwide, causing pain and limiting mobility, with conventional treatments often providing only temporary relief. Artery embolization (AE) represents a groundbreaking approach targeting the vascular component of joint inflammation. This minimally invasive procedure blocks abnormal blood vessels feeding...

Prostate cancer is the most common type of cancer in men and one of the main causes of death in developed countries of Europe and North America. The incidence of it has risen annually by 3% since 2014. Prostate cancer is the second-leading cause of death among males in the US. According to the American Cancer Society, about 1 in 44 men will die...

Amyotrophic lateral sclerosis (ALS) remains one of the most challenging neurological diseases, requiring innovative treatment approaches. German clinics hold leading positions in the development and implementation of advanced cell therapy methods, offering ALS patients scientifically-based treatment protocols with proven...

Therapeutic radionuclides Lutetium-177-PSMA, Actinium-225-PSMA, and Radium-223 have been successfully used in the treatment of advanced prostate cancer. These are modern drugs, in the development of which scientists have corrected the shortcomings of earlier used isotopes. With Actinium-225 emerging as a promising alternative to...

Prostate cancer is the most widespread type of oncological pathology among men. Doctors from all over the world pay attention to timely prophylaxis and diagnostics because at the early stages this disease is treated much easier. When the process is beyond the stage 1-3, especially when there are metastases in other organs and the skeleton...